NCT04247984 2022-03-11A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal CancerChineseAMSPhase 2 Completed264 enrolled